Xu-Dong Hou
- Molecular Biology
- Pharmacology top 10%
- Endocrinology, Diabetes and Metabolism
- Plant Science
- Complementary and alternative medicine top 10%
- Topics
- Pharmacology and Obesity Treatment (8 papers)Natural Antidiabetic Agents Studies (6 papers)SARS-CoV-2 and COVID-19 Research (3 papers)
- Journals
- SHILAP Revista de lepidopterologíaACS CatalysisPolymer
- Partner nations
- ChinaUnited StatesIran
In The Last Decade
Xu-Dong Hou
24 papers receiving 485 citations
Peers
Comparison fields: 5 of 81
- Molecular Biology 226
- Pharmacology 132
- Endocrinology, Diabetes and Metabolism 97
- Plant Science 77
- Complementary and alternative medicine 53
Countries citing papers authored by Xu-Dong Hou
This map shows the geographic impact of Xu-Dong Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu-Dong Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu-Dong Hou more than expected).
Fields of papers citing papers by Xu-Dong Hou
This network shows the impact of papers produced by Xu-Dong Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu-Dong Hou. The network helps show where Xu-Dong Hou may publish in the future.
Co-authorship network of co-authors of Xu-Dong Hou
This figure shows the co-authorship network connecting the top 25 collaborators of Xu-Dong Hou. A scholar is included among the top collaborators of Xu-Dong Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu-Dong Hou. Xu-Dong Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 6 | |
| 5 | 0 | |
| 6 | 3 | |
| 7 | 4 | |
| 8 | 10 | |
| 9 | 24 | |
| 10 | 17 | |
| 11 | 46 | |
| 12 | 30 | |
| 13 | 12 | |
| 14 | 6 | |
| 15 | 27 | |
| 16 | 34 | |
| 17 | 47 | |
| 18 | 54 | |
| 19 | 78 | |
| 20 | 10 |
About Xu-Dong Hou
Xu-Dong Hou is a scholar working on Pharmacology, Complementary and alternative medicine and Endocrinology, Diabetes and Metabolism, having authored 29 papers that have together received 487 indexed citations. Recurring topics across this work include Pharmacology and Obesity Treatment (8 papers), Natural Antidiabetic Agents Studies (6 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Biochemistry (49 citations), Pharmacology (132 citations) and Complementary and alternative medicine (53 citations). Xu-Dong Hou has collaborated with scholars based in China, United States and Iran. Frequent co-authors include Guang‐Bo Ge, Jie Hou, Zi-Miao Weng, Yun‐Feng Cao, Lele Ding, Ziru Dai, Yang Yu, Jie Hou, Xiao‐Qing Guan and Qi Zhou. Their work appears in journals such as SHILAP Revista de lepidopterología, ACS Catalysis and Polymer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.